Pharma Talks

In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground.

Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space.

Key takeaways:

• The real question isn't whether AI will replace jobs — it's whether we're willing to keep ways of working that can be replaced
• AI's value in pharma lies in augmenting HCP engagement, not just accelerating content volume
• Human experience and accumulated knowledge remain the irreplaceable edge in an AI-assisted environment
• Embracing agentic and generative AI tools requires genuine investment in understanding them — not expecting magic
• Those not actively adopting AI risk falling behind in an industry-wide shift already underway

📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk

🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/

Watch the first part of the conversation: https://youtu.be/PtR62juQ4FY

This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.

👥 Guests in this episode:

Bruno Senouci - co-CEO at DRCOM

Gwenael Meneux - co-CEO at DRCOM

Key Topics:

AI impact on pharma communication

Regional differences in Asia healthcare markets

Global to local content adaptation strategies

Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/

Follow Viseven and Nataliya, Bruno and Gwenael in social media:

https://www.linkedin.com/in/andreychuk/

https://www.linkedin.com/in/bsenouci/

https://www.linkedin.com/in/gwenael-meneux/?locale=fr

Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQ

This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.

👥 Guests in this episode:

Bruno Senouci - co-CEO at DRCOM

Gwenael Meneux - co-CEO at DRCOM

Key Topics:

AI impact on pharma communication

Regional differences in Asia healthcare markets

Global to local content adaptation strategies

Follow Viseven and Nataliya, Bruno and Gwenael in social media:

https://www.linkedin.com/in/andreychuk/

https://www.linkedin.com/in/bsenouci/

https://www.linkedin.com/in/gwenael-meneux/?locale=fr

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead.

Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the most exciting work? Using AI to genuinely improve the experience for HCPs and patients.

Key takeaways:

AI adoption in pharma is accelerating faster than most teams are ready for

Leadership intent is strong — but building the right skills across teams remains the gap

Generative AI is already embedded in day-to-day workflows — Copilot, emails, meetings

The biggest opportunity is using AI to enhance experiences for HCPs and patients, not just internal efficiency

Think beyond existing marketing models — combine them with technology to create innovative go-to-market approaches

📲 Enjoyed this episode?

👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode

👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.

Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.

Key takeaways:

• AI should be embedded where marketers already work — content, campaigns, reporting
• Contextual, always-on AI beats standalone tools nobody opens twice
• AI won't replace pharma marketers — human context in engagement is irreplaceable
• Before choosing a technology, map your end-to-end processes and define your goal first

📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/marc-koolen/

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.

With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.

Key takeaways:

AI in R&D and manufacturing is already mature — commercial operations are just catching up

Dark factories and agentic systems show what full automation can look like

The biggest opportunity isn't automating tasks — it's re-internalizing operational work with AI

Medical and scientific affairs are best positioned to lead the way right now

The advice that matters most: get your hands dirty and stay curious

📲 Enjoyed this episode?

👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode

👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

🔗 Follow & Connect:

🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/

🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.

Key takeaways:

- AI in pharma marketing requires systemic thinking, not point solutions

- Content without a delivery strategy is content that collects dust

- Modular content isn't dead — it's just often implemented too early

- Data hygiene and taxonomy are the boring work that makes everything else possible

--

📲 Enjoyed this episode?

👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode

👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)

--

🔗 Follow & Connect:

🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/

🎙 Yacin Marzouki → https://www.linkedin.com/in/yacin-m-customerengagement/

Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means

at the behaviour level.

Key Topics:

The gap between digital investment and actual engagement results

The importance of foundational architecture in customer engagement

The role of feedback loops in improving HCP interactions

Challenges of content personalization and regulation in pharma

Strategic content design and journey logic in omnichannel marketing

Chapters

00:00 Introduction to Customer Engagement Challenges

02:22 Understanding the Gap in Pharma Engagement

05:01 The Evolution of Customer Centricity

07:56 Architecting Effective Engagement Strategies

10:47 Content Creation and Regulatory Challenges

13:45 Intelligent Content Design for Better Engagement

16:25 Building a Feedback Loop for Success

18:01 Making Engagement Real and Effective

20:52 Practical Steps for Transformation

23:33 Final Thoughts and Recommendations

Follow Nataliya Andreychuk and Mark in social media:

https://www.linkedin.com/in/andreychuk/

linkedin.com/in/markwatsonuk

In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.

👥 Guests in this episode:

Rohit Khuttan — Practice Director, Everest Group

On AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change.

Ruslan Horblyuk — Chief Strategy Officer, AESARA

On AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary.

Nihar Patel — Business Development, Sun Pharma

On generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption.

Key topics covered:

Is Omnichannel really a content problem, not a channel problem?

How AI is changing content production and the pharma supply chain

Can we trust AI data in market access decisions?

Will AI replace pharma professionals — or make them smarter?

The three pharma disciplines AI will disrupt first

📲 Enjoyed this episode?

👉 Like, Subscribe & hit the to never miss a Pharma Talks episode

👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona